• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于神经疾病治疗的间充质干细胞的基因修饰:对表型/细胞行为有什么影响,从而决定其有效性?

Genetic Modification of Mesenchymal Stem Cells for Neurological Disease Therapy: What Effects Does it Have on Phenotype/Cell Behavior, Determining Their Effectiveness?

机构信息

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.

School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.

出版信息

Mol Diagn Ther. 2020 Dec;24(6):683-702. doi: 10.1007/s40291-020-00491-6.

DOI:10.1007/s40291-020-00491-6
PMID:32926348
Abstract

Mesenchymal stem cells are a promising tool in regenerative medicine, and their functions can be enhanced through genetic modification. Recent advances in genetic engineering provide several methods that enable gene delivery to mesenchymal stem cells. However, it remains to be decided whether genetic modification of mesenchymal stem cells by vectors carrying reporter or therapeutic genes leads to adverse effects on morphology, phenotypic profiles, and viability of transplanted cells. In this regard, we focus on the description of genetic modification methods of mesenchymal stem cells, their effectiveness, and the impact on phenotype/cell behavior/proliferation and the differentiation ability of these cells in vitro and in vivo. Furthermore, we compare the main effects of genetically modified mesenchymal stem cells with native mesenchymal stem cells when applied in the therapy of neurological diseases.

摘要

间充质干细胞是再生医学中一种有前途的工具,通过遗传修饰可以增强其功能。遗传工程的最新进展提供了几种方法,可以将基因递送到间充质干细胞中。然而,仍然需要确定携带报告基因或治疗基因的载体对间充质干细胞的遗传修饰是否会对移植细胞的形态、表型特征和活力产生不利影响。在这方面,我们重点描述了间充质干细胞的遗传修饰方法、它们的有效性以及对这些细胞在体外和体内的表型/细胞行为/增殖和分化能力的影响。此外,我们比较了在神经疾病治疗中应用的遗传修饰间充质干细胞与天然间充质干细胞的主要影响。

相似文献

1
Genetic Modification of Mesenchymal Stem Cells for Neurological Disease Therapy: What Effects Does it Have on Phenotype/Cell Behavior, Determining Their Effectiveness?用于神经疾病治疗的间充质干细胞的基因修饰:对表型/细胞行为有什么影响,从而决定其有效性?
Mol Diagn Ther. 2020 Dec;24(6):683-702. doi: 10.1007/s40291-020-00491-6.
2
Mesenchymal stem cells as a multimodal treatment for nervous system diseases.间充质干细胞作为一种多模态治疗神经系统疾病的方法。
Stem Cells Transl Med. 2020 Oct;9(10):1174-1189. doi: 10.1002/sctm.19-0430. Epub 2020 Jun 23.
3
Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: Mirage or reality?间充质干细胞作为治疗各种器官疾病的变革性工具:是幻想还是现实?
J Cell Physiol. 2019 Feb;234(2):1268-1288. doi: 10.1002/jcp.27152. Epub 2018 Sep 7.
4
Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma.多聚赖氨酸修饰的聚亚乙基亚胺聚合物可生成基因工程间充质干细胞,用于胶质母细胞瘤联合自杀基因治疗。
Acta Biomater. 2018 Oct 15;80:144-153. doi: 10.1016/j.actbio.2018.09.015. Epub 2018 Sep 15.
5
Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system.间充质干细胞在神经系统中的可塑性及治疗潜力
Curr Pharm Des. 2005;11(10):1255-65. doi: 10.2174/1381612053507495.
6
Human Bone Marrow Mesenchymal Stem Cells Functionalized by Hybrid Baculovirus-Adeno-Associated Viral Vectors for Targeting Hypopharyngeal Carcinoma.杂交杆状病毒-腺相关病毒载体转染骨髓间充质干细胞靶向下咽鳞癌的实验研究。
Stem Cells Dev. 2019 Apr 15;28(8):543-553. doi: 10.1089/scd.2018.0252. Epub 2019 Mar 11.
7
Improved therapeutic potential of MSCs by genetic modification.通过基因修饰提高间充质干细胞的治疗潜力。
Gene Ther. 2018 Dec;25(8):538-547. doi: 10.1038/s41434-018-0041-8. Epub 2018 Sep 25.
8
Genetic Manipulation and Selection of Mouse Mesenchymal Stem Cells for Delivery of Therapeutic Factors In Vivo.用于体内递送治疗因子的小鼠间充质干细胞的基因操作与筛选
Methods Mol Biol. 2019;1940:143-155. doi: 10.1007/978-1-4939-9086-3_10.
9
Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI.基因修饰间充质干细胞:创伤性脑损伤基于干细胞治疗的下一代。
Int J Mol Sci. 2020 Jun 5;21(11):4051. doi: 10.3390/ijms21114051.
10
Ex vivo gene therapy for the treatment of neurological disorders.用于治疗神经系统疾病的离体基因疗法。
Prog Brain Res. 2017;230:99-132. doi: 10.1016/bs.pbr.2016.11.003. Epub 2017 Jan 17.

引用本文的文献

1
Genetic modification of mesenchymal stem cells (MSCs): novel strategy to expand their naïve applications in critical illness.间充质干细胞(MSCs)的基因改造:扩大其在危重症中原始应用的新策略。
Mol Biol Rep. 2025 May 24;52(1):501. doi: 10.1007/s11033-025-10570-8.
2
Evaluation of mesenchymal stem cells as an model for inherited retinal diseases.间充质干细胞作为遗传性视网膜疾病模型的评估。
Front Cell Dev Biol. 2024 Nov 15;12:1455140. doi: 10.3389/fcell.2024.1455140. eCollection 2024.
3
Potential applications of mesenchymal stem cells and their derived exosomes in regenerative medicine.

本文引用的文献

1
GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson's Disease.GDNF 促进人脂肪间充质干细胞在帕金森病小鼠模型中的存活和治疗效果。
Cell Transplant. 2020 Jan-Dec;29:963689720908512. doi: 10.1177/0963689720908512.
2
Transplantation of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 Facilitates Cognitive Recovery and Enhances Neurogenesis in a Mouse Model of Traumatic Brain Injury.成纤维细胞生长因子 21 过表达骨髓间充质干细胞促进创伤性脑损伤小鼠认知功能恢复和神经发生。
J Neurotrauma. 2020 Jan 1;37(1):14-26. doi: 10.1089/neu.2019.6422. Epub 2019 Aug 20.
3
间充质干细胞及其衍生的外泌体在再生医学中的潜在应用。
Expert Opin Biol Ther. 2023 Jan-Jun;23(6):491-507. doi: 10.1080/14712598.2023.2211203. Epub 2023 May 9.
4
Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders.基于间充质干细胞的溶酶体贮积症及其他神经退行性疾病治疗方法
Front Pharmacol. 2022 Mar 2;13:859516. doi: 10.3389/fphar.2022.859516. eCollection 2022.
Effects of GDNF-Transfected Marrow Stromal Cells on Rats with Intracerebral Hemorrhage.
胶质细胞源性神经营因子转染的骨髓基质细胞对脑出血大鼠的影响。
J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2555-2562. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.002. Epub 2019 Jun 24.
4
Transplantation of mesenchymal stem cells overexpressing interleukin-10 induces autophagy response and promotes neuroprotection in a rat model of TBI.过表达白细胞介素-10 的间充质干细胞移植诱导自噬反应并促进 TBI 大鼠模型的神经保护。
J Cell Mol Med. 2019 Aug;23(8):5211-5224. doi: 10.1111/jcmm.14396. Epub 2019 Jun 4.
5
Lin28B regulates the fate of grafted mesenchymal stem cells and enhances their protective effects against Alzheimer's disease by upregulating IGF-2.Lin28B 通过上调 IGF-2 调节移植间充质干细胞的命运并增强其对阿尔茨海默病的保护作用。
J Cell Physiol. 2019 Dec;234(12):21860-21876. doi: 10.1002/jcp.28750. Epub 2019 May 8.
6
Protective effects of mesenchymal stem cells overexpressing extracellular regulating kinase 1/2 against stroke in rats.过表达细胞外调节激酶 1/2 的间充质干细胞对大鼠卒中的保护作用。
Brain Res Bull. 2019 Jul;149:42-52. doi: 10.1016/j.brainresbull.2019.04.006. Epub 2019 Apr 16.
7
Recombinant Viral Vectors as Neuroscience Tools.重组病毒载体作为神经科学工具
Curr Protoc Neurosci. 2019 Apr;87(1):e67. doi: 10.1002/cpns.67. Epub 2019 Mar 22.
8
Design of AAV Vectors for Delivery of Large or Multiple Transgenes.用于递送大基因或多个转基因的腺相关病毒载体设计
Methods Mol Biol. 2019;1950:19-33. doi: 10.1007/978-1-4939-9139-6_2.
9
Generation of High-Titer Pseudotyped Lentiviral Vectors.高滴度假型慢病毒载体的产生
Methods Mol Biol. 2019;1937:125-134. doi: 10.1007/978-1-4939-9065-8_7.
10
Safety and efficacy evaluations of an adeno-associated virus variant for preparing IL10-secreting human neural stem cell-based therapeutics.腺相关病毒变异体用于制备分泌 IL10 的人神经干细胞治疗药物的安全性和疗效评价。
Gene Ther. 2019 May;26(5):135-150. doi: 10.1038/s41434-019-0057-8. Epub 2019 Jan 28.